Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Jan;51(1):55-60.
doi: 10.1128/JCM.02002-12. Epub 2012 Oct 17.

Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis

Affiliations
Comparative Study

Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis

Erin Rottinghaus et al. J Clin Microbiol. 2013 Jan.

Abstract

Dried blood spots (DBS) collected onto filter paper have eased the difficulty of blood collection in resource-limited settings. Currently, Whatman 903 (W-903) filter paper is the only filter paper that has been used for HIV load and HIV drug resistance (HIVDR) testing. We therefore evaluated two additional commercially available filter papers, Ahlstrom grade 226 (A-226) and Munktell TFN (M-TFN), for viral load (VL) testing and HIVDR genotyping using W-903 filter paper as a comparison group. DBS specimens were generated from 344 adult patients on antiretroviral therapy (ART) in Botswana. The VL was measured with NucliSENS EasyQ HIV-1 v2.0, and genotyping was performed for those specimens with a detectable VL (≥ 2.90 log(10) copies/ml) using an in-house method. Bland-Altman analysis revealed a strong concordance in quantitative VL analysis between W-903 and A-226 (bias = -0.034 ± 0.246 log(10) copies/ml [mean difference ± standard deviation]) and W-903 and M-TFN (bias = -0.028 ± 0.186 log(10) copies/ml) filter papers, while qualitative VL analysis for virological failure determination, defined as a VL of ≥ 3.00 log(10) copies/ml, showed low sensitivities for A-266 (71.54%) and M-TFN (65.71%) filter papers compared to W-903 filter paper. DBS collected on M-TFN filter paper had the highest genotyping efficiency (100%) compared to W-903 and A-226 filter papers (91.7%) and appeared more sensitive in detecting major HIVDR mutations. DBS collected on A-226 and M-TFN filter papers performed similarly to DBS collected on W-903 filter paper for quantitative VL analysis and HIVDR detection. Together, the encouraging genotyping results and the variability observed in determining virological failure from this small pilot study warrant further investigation of A-226 and M-TFN filter papers as specimen collection devices for HIVDR monitoring surveys.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Bland-Altman analysis of HIV-1 load quantification between A-226 (A) or M-TFN (B) and W-903 filter papers. Nucleic acid was extracted from DBS specimens by using the NucliSENS EasyMag automated system, and NucliSENS HIV-1 v2.0 RUO kits were used to determine the HIV-1 load using the NucliSENS EasyQ analyzer. Twenty-four specimens with a detectable viral load (VL) (defined as a VL of ≥2.90 log10 copies/ml) with all three types of filter paper were included in the analyses. The solid line represents the mean difference between W-903 and A-226 (−0.034 ± 0.246 log10 copies/ml) or W-903 and M-TFN (−0.028 ± 0.186 log10 copies/ml) filter papers, and the dotted lines represent the 95% limits of agreement (mean difference ± 1.96 standard deviations) for A-226 (−0.517 and 0.449; width = 0.965) and M-TFN (−0.393 and 0.336; width = 0.728) filter papers.

References

    1. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. 2008. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther. 13(Suppl 2):1–13 - PubMed
    1. Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. 2008. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir. Ther. 13(Suppl 2):15–23 - PubMed
    1. WHO 2010. WHO manual for HIV drug resistance testing using dried blood spot specimens. WHO, Geneva, Switzerland
    1. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF. 2009. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir. Ther. 14:619–629 - PubMed
    1. Bertagnolio S, Soto-Ramirez L, Pilon R, Rodriguez R, Viveros M, Fuentes L, Harrigan PR, Mo T, Sutherland D, Sandstrom P. 2007. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12:107–113 - PubMed

Publication types

Grants and funding